07:30

08:20

09:15

10:20 Co�ee Break

10:35

11:20

12:15

ResoTher Pharma ApS

Crescendo Biologics Ltd.

IGEM Therapeutics Ltd.

PDC*line Pharma SA

Aurealis Pharma AG

Step Pharma SAS

ATRIVA Therapeutics GmbH

Signia Therapeutics

Adrenomed AG

Forendo Pharma Ltd.

Priavoid GmbH

11:00

11:10

11:20

11:30

11:40

11:50

12:00

12:10

12:20

12:30

12:40

12:50

Registration & Co�ee - Day One, 26th February 2018

Welcome Speech by Leonard Sachs, Managing Director, Sachs Associates

“Going and Being Public: an Interview with Miguel Payró, CFO of GeNeuro SA, Geneva” by Dr. Søren Bjønness, Director – Swiss Representative, EURONEXT

08:30

“Prospects for 2018”- Global Biopharma Industry Review PanelChaired by:Stephanie Léouzon, Principal and Head of Torreya Partners Europe, Torreya Partners (Europe) LLPPanelists:Ari-Pekka Laitsaari, Senior Investment O�cer, European Investment BankChandra Leo, Investment Advisor, HBM Partners AGMark Altmeyer, President & CCO, Axovant SciencesNicholas Franco, EVP & Chief Business Development O�cer, Actelion, a Janssen Pharmaceuticals Company of Johnson & JohnsonNooman Haque, Managing Director, Life Sciences & Healthcare, Silicon Valley Bank

“Latest Trends in Fund Raising and Investment” - Private Equity and VC PanelCo-Chaired by:Annegret de Baey, Venture Partner, Seventure PartnersMarkus Hosang, General Partner, BioMedPartners AGPanelists:Adelaide Cracco, Head of Life Sciences, European Investment FundCharles Kunsch, Director, AbbVie VenturesIain Dukes, Venture Partner, OrbiMed Advisors, LLCOlivier Litzka, Partner, Edmond de Rothschild Investment Partners S.A.S.Tim Haines, Managing Partner, Abingworth LLP

“Capital Raising and Investment Opportunities” - European Equity Capital Markets PanelCo-Chaired by:Chris Maggos, Managing Director, Europe, LifeSci Advisors, LLCPaul Hermant, Partner, Bird & Bird LLPPanelists:Bartjan van Hulten, Founder, Medex CapitalGil Bar-Nahum, Managing Director, Je�eries International LimitedHartmut Ehrlich, CEO, ABIVAXJörg Neermann, Partner, LSPThibaut Roulon, Investment Director, Bpifrance

Neuroscience I – BD&L PanelChaired by:Jennifer Laird, Senior Director, Search & Evaluation, Eli Lilly & CompanyPanelists:Carlos Buesa, CEO & Founder, Oryzon Genomics SAGregor Macdonald, Senior Director, Neuroscience Scienti�c Licensing, Johnson & JohnsonIsabel Ferreira, Director, Global Business Development, F. Ho�mann-La Roche Ltd.Jørgen Drejer, CEO, Saniona ABKlaus Mendla, Global Head of CNS BD&L, Boehringer Ingelheim Pharma GmbH & Co. KG

Neuroscience II – Advanced Therapies and Diagnostics PanelCo-Chaired by:Alexander Breidenbach, Global Head Neuroscience, Ophthalmology & Rare Diseases Partnering,F. Ho�mann-La Roche Ltd.Keno Gutierrez, Investment Director, Merck VenturesPanelists:Declan Jones, VP, Neuroscience Lead, Johnson & Johnson InnovationDirk Beher, CEO, Asceneuron SAGunilla Osswald, President & CEO, BioArctic ABJim DeMesa, CEO, Emerald Health Pharmaceuticals, Inc.Lynn Durham, CEO & Founder, Stalicla SAMichael Almstetter, CEO, Origenis GmbHMichael Scherz, Founder & CEO, Metys Pharmaceuticals AG

EUROPEAN LIFE SCIENCES CEO FORUMSwitzerlandHilton Zurich Airport Hotelth

Partnering and Investing in Biotech & Pharma Industry26 - 27 February 2018th

ANNUAL11

th

09:35

13:00 Networking Lunch

PR Track A - Room BerneModerated by:

Lorenza Castellon, Independent Consultant

BioLingus AG

Room Panorama

Room Panorama

Room Panorama A

Room Panorama A

Room Panorama A

For Wi-Fi Connect to:Honors

Advances in C&G Therapies PanelCo-Chaired by:Alain Vertes, Managing Director, NxR Biotechnologies GmbHZhiZhong Yao, Associate, So�nnova PartnersPanelists:Eric Halioua, President & CEO, PDC*line Pharma SAGabriele Proetzel, Director, Regenerative Medicine, Takeda Pharmaceuticals International AGOlav Hellebo, CEO, ReNeuron Group PLCSarah Holland, Global Head of Licensing, Lonza AGStefanos Theoharis, SVP, Partnering and Corporate Development, Cell MedicaSven Kili, VP & Head of Gene Therapy Development, GlaxoSmithKline

Platform Technologies and Novel Therapeutics PanelChaired by:Nanna Luneborg, Partner, Novo VenturesPanelists:Anker Lundemose, CEO, MISSION Therapeutics Ltd.Christian Jung, Principal, Wellington Partners GmbHHeinz Lubenau, COO, VAXIMM AGJulian Bertschinger, VP, Head Therapeutic Platform Innovation, Janssen Research & Development, LLCOlivier Soula, Deputy General Manager, R&D Director, AdociaYochi Slonim, CEO, Anima Biotech Ltd.

Co�ee Break

16:25

Networking Reception

End of the Networking Reception and Day One

BAYOOMED Medical Software

Origenis GmbH

Upstream Medical Technologies Ltd.

Cellerys AG

Protein Alternatives S.L. (ProAlt)

PR Track E - Room BerneModerated by:

Jørgen Thorball, XOventure GmbH

PR Track B - Room Panorama AModerated by:

Hans Herklots, LifeSci Advisors, LLC

PR Track C - Room Panorama CModerated by:

Sue Charles, Instinctif Partners

PR Track D - Room BerneModerated by:

Wilder Fulford, The Fulford Group Ltd.

Asceneuron SA

Metys Pharmaceuticals AG

Emerald Health Pharmaceuticals, Inc.

Oryzon Genomics SA [BME:ORY]

Saniona AB [STO:SANION]

Stalicla SA

BioArctic AB [STO:BIOA-B]

Addex Therapeutics Ltd. [SWX:ADXN]

ABIVAX [EPA:ABVX]

NetScienti�c PLC [LON:NSCI]

Anima Biotech Ltd.

VAXIMM AG

MOLOGEN AG [ETR:MGN]

Opsona Therapeutics Ltd.

InSphero AG

InCarda Therapeutics, Inc.

MEDICEM Institute S.R.O

Caelus Health

MangoGen Pharma, Inc.

4D Lifetec AG

Dermadis SAS

Imcyse SA

AYOXXA Biosystems GmbH

Lipocalyx GmbH

14:00

13:00

16:15

14:15

14:30

14:45

15:00

15:15

15:30

15:45

Networking Lunch

16:00

17:00

16:15

16:35

16:45

16:55

17:45

20:00

SILVER SPONSORS:

SUPPORTED BY:

Room Panorama A

Room Panorama A

Oncology I – DealMaking PanelCo-Chaired by:Esteban Pombo-Villar, CEO, TargImmune Therapeutics AGMark Krul, Director, Aglaia BioMedical VenturesPanelists:Göran Forsberg, CEO, Cantargia ABHelen Tayton-Martin, CBO, Adaptimmune TherapeuticsKhatereh Ahmadi, Executive Director, Oncology BD&L, MSDMark Vaeck, CEO, Complix NVMatthias Müllenbeck, Director Global Licensing and BD Oncology, Merck KGaAPer Norlén, CEO, Alligator Bioscience ABPeter Pack, CEO, Crescendo Biologics Ltd.

“Key players Focusing on DealMaking to Alliance Management” - Bio-Pharma Partnering PanelChaired by:Fintan Walton, CEO, PharmaVentures Ltd.Panelists:Berthold Hinzen, Head BD&L General Medicine, Bayer HealthCare Pharmaceuticals, LLCConstantine Chinoporos, CBO, Boston Pharmaceuticals, Inc.Isabelle Heit, Director Global Alliance Management, Takeda Pharmaceuticals International AGLubor Gaal, Head of Licensing and External Innovation, Almirall S.A.Patrick Benz, Senior Director Alliance Management, Janssen, Pharmaceutical Companies of Johnson & JohnsonPhil L'Huillier, Head, European Innovation Hub, MSD

"The Future of Personalized Healthcare: The Interplay of Diseases, Information and Technologies" by Miro Venturi, Global Head - Diagnostics Biomarkers, F. Ho�mann-La Roche Ltd.

Co�ee Break

Oncology II – Advanced Therapies and Diagnostics Panel Co-Chaired by: François Thomas, Partner, Inserm Transfert Initiative Tim Herpin, Vice President, Head of Transactions, Business Development, AstraZenecaPanelists:Corinne Danan, EVP, Partnerships BU, HalioDxJuergen Gamer, VP BD, Apogenix AGMichael Bauer, CEO, Cellestia Biotech AGStéphane Degove, CEO, GamaMabs Pharma SAUlrich Kessler, CEO, Inthera Bioscience AG

09:00

09:45

10:05

11:00

11:15

12:00

Early Stage Innovation PanelCo-Chaired by:Holger Schwarz, Director, Global Head of Search & Evaluation Discovery Technologies, Merck KGaAMichèle Ollier, Partner, Medicxi VenturesPanelists:Anja König, Managing Director, Novartis Venture FundDani Bach, Healthcare Investment Director, Touchstone InnovationsErnst Hafen, Director of Studies, ETH Zurich (IMSB)Frauke Hein, CBO, Adrenomed AGNathalie ter Wengel, European Head External R&D and Innovation, P�zer, Inc.Pavithra Sundaresan, Senior Director New Ventures and Transactions, Johnson & Johnson Innovation

PR Track F - Room Panorama CModerated by:

Jørgen Thorball, XOventure GmbH

PR Track G - Room BerneModerated by:

Hans Herklots, LifeSci Advisors, LLC

BRASTER S.A. [BRA:WSE]

IDP Discovery Pharma S.L.

Cellestia Biotech AG

GamaMabs Pharma SA

Cantargia AB [CANTA:FN]

Alligator Bioscience AB [STO:ATORX]

Apogenix AG

EUROPEAN LIFE SCIENCES CEO FORUMSwitzerlandHilton Zurich Airport Hotelth

Partnering and Investing in Biotech & Pharma Industry26 - 27 February 2018th

ANNUAL11

th

08:30

Networking Lunch13:00

Registration & Co�ee - Day Two, 27th February 2018

12:00

12:15

12:30

12:45

SILVER SPONSORS:

SUPPORTED BY:

Room Panorama

Room Panorama

Room Panorama

Room Panorama A

Networking Lunch

Seed Companies Investor RoundtableCo-Chaired by:Dragan Grabulovski, CEO & Founder, Grabulovski Consulting ServicesJeanne Bolger, Vice President, Venture Investments, Johnson & Johnson InnovationPanelists: Alethia de Leon, Managing Director, BaseLaunchChristina Trojel-Hansen, Senior Investment Associate, Novo Holdings A/SFiona MacLaughlin, Director, Inkef CapitalHans-Florian Zeilhofer, Associate Vice President Innovation, University of BaselJakob Busch-Petersen, Intrapreneur, F. Ho�mann-La Roche Ltd.Paul Ashley, Head of Technology Transfer, Oxford University Innovation Ltd.

Rising Stars: Start-Up ShowcaseModerated by:Rao Movva, Pharma and Biotech Advisor & MentorUlrich Muehlner, Co-Founder & CEO, docdok.health AG

Presenting Order:1. Tepthera2. TheraNash Program3. Saverna Therapeutics4. CDR-Life AG5. Araris Biotech AG6. Clemedi7. NovaGo Therapeutics AG

Last Chance to Network - Farewell Reception

End of the ELSCEO Forum

13:00

14:00

15:00

16:00

16:30

SILVER SPONSORS:

SUPPORTED BY:

Room Panorama

Room Panorama

PicoDNAVelox therapeutics8.

9. 10. Prolongate11. REM Analytics12. ABCDx - Advanced Brain Companion Diagnostics13. Dicronis14. docdok.health AG